Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
L. P. Andersen, A. Dorland, H. Karacan, H. Colding, H.- O. Nilsson, T. Wadström, J. Blom. (2000) Possible Clinical Importance of the Transformation of Helicobacter pylori into Coccoid Forms. Scandinavian Journal of Gastroenterology 35:9, pages 897-903.
Read now
Read now
V. Ellenrieder, W. Boeck, C. Richter, R. Marre, G. Adler, B. Glasbrenner. (1999) Prevalence of Resistance to Clarithromycin and Its Clinical Impact on the Efficacy of Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 34:8, pages 750-756.
Read now
Read now
Articles from other publishers (22)
Nagendran Tharmalingam, Rajamohammed Khader, Beth Burgwyn Fuchs & Eleftherios Mylonakis. (2019) The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus. Frontiers in Microbiology 10.
Crossref
Crossref
L. V. Kitaeva, I. A. Mikhailova, D. M. Semov, S. N. Proshin & V. Yu. Kravtsov. (2008) Mucocytes with micronuclei and sowing with the coccoid forms of Helicobacter pylori in a mucous membrane of human stomach. Cell and Tissue Biology 2:2, pages 170-175.
Crossref
Crossref
Emily Lane, Remo Lobetti & Richard Burroughs. (2004) TREATMENT WITH OMEPRAZOLE, METRONIDAZOLE, AND AMOXICILLIN IN CAPTIVE SOUTH AFRICAN CHEETAHS (ACINONYX JUBATUS) WITH SPIRAL BACTERIAINFECTION AND GASTRITIS. Journal of Zoo and Wildlife Medicine 35:1, pages 15-19.
Crossref
Crossref
Tomoyuki Ohno, Masakazu Kita, Yoshio Yamaoka, Shigeyoshi Imamura, Toshiro Yamamoto, Shoji Mitsufuji, Tadashi Kodama, Kei Kashima & JirO Imanishi. (2003) Antimicrobial Activity of Essential Oils against Helicobacter pylori. Helicobacter 8:3, pages 207-215.
Crossref
Crossref
F. A. Al‐Eidan, J. C. McElnay, M. G. Scott & J. B. McConnell. (2002)
Management of
Helicobacter pylori
eradication – the influence of structured counselling and follow‐up
. British Journal of Clinical Pharmacology 53:2, pages 163-171.
Crossref
Crossref
Francis Mégraud. 2002. Macrolide Antibiotics. Macrolide Antibiotics
243
260
.
Yoshimasa Yamamoto. 2002. Helicobacter pylori Infection and Immunity. Helicobacter pylori Infection and Immunity
105
119
.
A. Francavilla & E. Ierardi. (2000) Helicobacter species in liver and biliary diseases. Digestive and Liver Disease 32, pages 217-219.
Crossref
Crossref
Katsuhiro Mabe, Masami Yamada, Itaro Oguni & Tsuneo Takahashi. (1999)
In Vitro and In Vivo Activities of Tea Catechins against
Helicobacter pylori
. Antimicrobial Agents and Chemotherapy 43:7, pages 1788-1791.
Crossref
Crossref
Sieg, Sellinger, Schlauch, HÖrner & Fuchs. (2001)
Short‐term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 13:7, pages 865-868.
Crossref
Crossref
Min Wen, Yali Zhang, Nobutaka Yamada, Takeshi Matsuhisa, Norio Matsukura & Yuichi Sugisaki. (2002)
An evaluative system for the response of antibacterial therapy: Based on the morphological change of
Helicobacter pylori
and mucosal inflammation
. Pathology International 49:4, pages 332-337.
Crossref
Crossref
Seiichi KatoHideyo RitsunoKenji OhnumaKazuie IinumaToshiro Sugiyama & Masahiro Asaka. (2006)
Safety and Efficacy of One‐Week Triple Therapy for Eradicating
Helicobacter pylori
in Children
. Helicobacter 3:4, pages 278-282.
Crossref
Crossref
Ellenrieder, Fensterer, Waurick, Adler & Glasbrenner. (2001) Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Alimentary Pharmacology & Therapeutics 12:7, pages 613-618.
Crossref
Crossref
TAKAHISA FURUTA, MISAKO TAKASHIMA, HAJIME FUTAMI, HAJIME ARAI, HIROYUKI HANAI & EIZO KANEKO. (2008)
Amount of
Helicobacter pylori
in gastric mucus during anti‐
H. pylori
treatment
. Journal of Gastroenterology and Hepatology 13:5, pages 511-515.
Crossref
Crossref
Bazzoli, Zagari, Pozzato, Varoli, Fossi, Ricciardiello, Alampi, Nicolini, Sottili, Simoni, Roda & Roda. (2001) Evaluation of short‐term low‐dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double‐blind, controlled study. Alimentary Pharmacology & Therapeutics 12:5, pages 439-445.
Crossref
Crossref
N DAL BO’, F DI MARIO, G BATTAGLIA, A BUDA, G LEANDRO, F VIANELLO, S KUSSTATSCHER, S SALANDIN, A PILOTTO, M CASSARO, S VIGNERI & M RUGGE. (2009)
Low dose of clarithromycin in triple therapy for the eradication of
Helicobacter pylori
: One or two weeks?
. Journal of Gastroenterology and Hepatology 13:3, pages 288-293.
Crossref
Crossref
M.D. Willard. (1998) Gastrointestinal Drugs. Veterinary Clinics of North America: Small Animal Practice 28:2, pages 377-394.
Crossref
Crossref
Jun Cao, Zhao Q Li, Kurt Borch, Fredrik Petersson & Sven Mårdh. (1997) Detection of spiral and coccoid forms of Helicobacter pylori using a murine monoclonal antibody. Clinica Chimica Acta 267:2, pages 183-196.
Crossref
Crossref
Min Wen, Nobutaka Yamada, Yali Zhang & Takeshi Matsuhisa. (1997) Morphological changes ofHelicobacter pylori after antibacterial therapy: an electron microscope study. Medical Electron Microscopy 30:3, pages 131-137.
Crossref
Crossref
JIA-QING HUANG & RICHARD H HUNT. (1997) Review: Eradication of Helicobacter pylori. Problems and recommendations. Journal of Gastroenterology and Hepatology 12:8, pages 590-598.
Crossref
Crossref
Takuya Takimoto, Kiichi Satoh, Yushi Taniguchi, Koji Saifuku, Ken Kihira, Masaru Seki, Yukio Yoshida, Kenichi Ido & Ken Kimura. (2008)
The Efficacy and Safety of One‐Week Triple Therapy with Lansoprazole, Clarithromycin, and Metronidazole for the Treatment of
Helicobacter pylori
Infection in Japanese Patients
. Helicobacter 2:2, pages 86-91.
Crossref
Crossref
Paul Moayyedi & Michael F. Dixon. (1997) Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening. Gastrointestinal Endoscopy Clinics of North America 7:1, pages 47-64.
Crossref
Crossref